Literature DB >> 18927591

Genomic-scale prioritization of drug targets: the TDR Targets database.

Fernán Agüero1, Bissan Al-Lazikani, Martin Aslett, Matthew Berriman, Frederick S Buckner, Robert K Campbell, Santiago Carmona, Ian M Carruthers, A W Edith Chan, Feng Chen, Gregory J Crowther, Maria A Doyle, Christiane Hertz-Fowler, Andrew L Hopkins, Gregg McAllister, Solomon Nwaka, John P Overington, Arnab Pain, Gaia V Paolini, Ursula Pieper, Stuart A Ralph, Aaron Riechers, David S Roos, Andrej Sali, Dhanasekaran Shanmugam, Takashi Suzuki, Wesley C Van Voorhis, Christophe L M J Verlinde.   

Abstract

The increasing availability of genomic data for pathogens that cause tropical diseases has created new opportunities for drug discovery and development. However, if the potential of such data is to be fully exploited, the data must be effectively integrated and be easy to interrogate. Here, we discuss the development of the TDR Targets database (http://tdrtargets.org), which encompasses extensive genetic, biochemical and pharmacological data related to tropical disease pathogens, as well as computationally predicted druggability for potential targets and compound desirability information. By allowing the integration and weighting of this information, this database aims to facilitate the identification and prioritization of candidate drug targets for pathogens.

Entities:  

Mesh:

Year:  2008        PMID: 18927591      PMCID: PMC3184002          DOI: 10.1038/nrd2684

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  24 in total

1.  MODBASE, a database of annotated comparative protein structure models, and associated resources.

Authors:  Ursula Pieper; Narayanan Eswar; Hannes Braberg; M S Madhusudhan; Fred P Davis; Ashley C Stuart; Nebojsa Mirkovic; Andrea Rossi; Marc A Marti-Renom; Andras Fiser; Ben Webb; Daniel Greenblatt; Conrad C Huang; Thomas E Ferrin; Andrej Sali
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

Review 2.  The druggable genome.

Authors:  Andrew L Hopkins; Colin R Groom
Journal:  Nat Rev Drug Discov       Date:  2002-09       Impact factor: 84.694

3.  Contribution of structural biology to clinically validated target proteins.

Authors:  Masumi Mori; Naoko Ogawa; Kunihiro Tanikawa; Sanae Dodo; Sotaro Shibayama; Shigeyuki Yokoyama; Akiko Tanaka
Journal:  Drug Discov Today       Date:  2008-04-28       Impact factor: 7.851

4.  Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei. In vitro RNA interference and in vivo inhibition studies.

Authors:  Andrea Montalvetti; Alexis Fernandez; John M Sanders; Subhash Ghosh; Erin Van Brussel; Eric Oldfield; Roberto Docampo
Journal:  J Biol Chem       Date:  2003-03-04       Impact factor: 5.157

5.  Experimental determination and system level analysis of essential genes in Escherichia coli MG1655.

Authors:  S Y Gerdes; M D Scholle; J W Campbell; G Balázsi; E Ravasz; M D Daugherty; A L Somera; N C Kyrpides; I Anderson; M S Gelfand; A Bhattacharya; V Kapatral; M D'Souza; M V Baev; Y Grechkin; F Mseeh; M Y Fonstein; R Overbeek; A-L Barabási; Z N Oltvai; A L Osterman
Journal:  J Bacteriol       Date:  2003-10       Impact factor: 3.490

6.  A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis.

Authors:  Gyanu Lamichhane; Matteo Zignol; Natalie J Blades; Deborah E Geiman; Annette Dougherty; Jacques Grosset; Karl W Broman; William R Bishai
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-29       Impact factor: 11.205

7.  Purine salvage pathways in the apicomplexan parasite Toxoplasma gondii.

Authors:  Kshitiz Chaudhary; John A Darling; Leah M Fohl; William J Sullivan; Robert G K Donald; Elmer R Pfefferkorn; Buddy Ullman; David S Roos
Journal:  J Biol Chem       Date:  2004-05-11       Impact factor: 5.157

8.  Systematic functional analysis of the Caenorhabditis elegans genome using RNAi.

Authors:  Ravi S Kamath; Andrew G Fraser; Yan Dong; Gino Poulin; Richard Durbin; Monica Gotta; Alexander Kanapin; Nathalie Le Bot; Sergio Moreno; Marc Sohrmann; David P Welchman; Peder Zipperlen; Julie Ahringer
Journal:  Nature       Date:  2003-01-16       Impact factor: 49.962

9.  OrthoMCL: identification of ortholog groups for eukaryotic genomes.

Authors:  Li Li; Christian J Stoeckert; David S Roos
Journal:  Genome Res       Date:  2003-09       Impact factor: 9.043

10.  Genes required for mycobacterial growth defined by high density mutagenesis.

Authors:  Christopher M Sassetti; Dana H Boyd; Eric J Rubin
Journal:  Mol Microbiol       Date:  2003-04       Impact factor: 3.501

View more
  122 in total

1.  In silico work flow for scaffold hopping in Leishmania.

Authors:  Barnali Waugh; Ambarnil Ghosh; Dhananjay Bhattacharyya; Nanda Ghoshal; Rahul Banerjee
Journal:  BMC Res Notes       Date:  2014-11-17

Review 2.  Chemistry and biology of multicomponent reactions.

Authors:  Alexander Dömling; Wei Wang; Kan Wang
Journal:  Chem Rev       Date:  2012-03-22       Impact factor: 60.622

Review 3.  Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy.

Authors:  Margaret A Phillips; Pradipsinh K Rathod
Journal:  Infect Disord Drug Targets       Date:  2010-06

4.  ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr.

Authors:  John Overington
Journal:  J Comput Aided Mol Des       Date:  2009-02-05       Impact factor: 3.686

Review 5.  Using genetic findings in autism for the development of new pharmaceutical compounds.

Authors:  Jacob A S Vorstman; Will Spooren; Antonio M Persico; David A Collier; Stefan Aigner; Ravi Jagasia; Jeffrey C Glennon; Jan K Buitelaar
Journal:  Psychopharmacology (Berl)       Date:  2013-11-30       Impact factor: 4.530

6.  Strategic protein target analysis for developing drugs to stop dental caries.

Authors:  J A Horst; U Pieper; A Sali; L Zhan; G Chopra; R Samudrala; J D B Featherstone
Journal:  Adv Dent Res       Date:  2012-09

7.  Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.

Authors:  Sonya C Tang; Theresa A Shapiro
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

8.  Elucidating the structural basis of diphenyl ether derivatives as highly potent enoyl-ACP reductase inhibitors through molecular dynamics simulations and 3D-QSAR study.

Authors:  Pharit Kamsri; Auradee Punkvang; Patchareenart Saparpakorn; Supa Hannongbua; Stephan Irle; Pornpan Pungpo
Journal:  J Mol Model       Date:  2014-06-17       Impact factor: 1.810

9.  Investigating mammalian tyrosine phosphatase inhibitors as potential 'piggyback' leads to target Trypanosoma brucei transmission.

Authors:  Irene Ruberto; Balazs Szoor; Rachel Clark; Keith R Matthews
Journal:  Chem Biol Drug Des       Date:  2013-02       Impact factor: 2.817

Review 10.  New medicines to improve control and contribute to the eradication of malaria.

Authors:  Timothy N C Wells; Pedro L Alonso; Winston E Gutteridge
Journal:  Nat Rev Drug Discov       Date:  2009-10-16       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.